The Food and Drug Administration recommended Mylan Chief Executive Officer Heather Bresch hire a consultant to help the generic drugmaker improve its manufacturing practices... Sep 03
Nepal's Medical Council's directive (Interim Clinical Guidance for COVID-19) also has enlisted Remdesivir drug for the primary medication.... Aug 22
Cipla had earlier said pricing would not exceed 5,000 rupees. On Tuesday, Sovereign Pharma, which is manufacturing and packaging the drug for Cipla... Jul 09
The CHMP positive opinion will now be considered by the European Commission (EC). Once approved the EC will grant a centralized marketing authorization for member ... Mar 28
CEO of BIOCON confirmed "We are extremely pleased with the U.S. court ruling in favour of our Insulin Glargine device as this takes us ... Mar 12
Biocon and Mylan’s proposed biosimilar bevacizumab is expected to be the third biosimilar from the partnered portfolio for the cancer patients in the U.... Mar 12
True North to invest 536.24 crores in Biocon for 2.44% minority stake... Jan 07